Costa Rica vs Madagascar: Previously treated cases tested for RR-/MDR-TB
Costa Rica
62.0%
in 2024
Madagascar
69.0%
in 2024
Costa Rica rank
135th
Madagascar rank
134th
Previously treated cases tested for RR-/MDR-TB over time
- Costa Rica
- Madagascar
How they compare
Madagascar currently reports 69.0% against 62.0% in Costa Rica, a difference of 7.0%.
That makes Madagascar's figure about 1.1 times Costa Rica's.
The two have swapped places 7 times across 15 shared years of data; in 2006 it was Costa Rica ahead.
Costa Rica ranks 135th and Madagascar ranks 134th of 180 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 4.7% | 95.3% | Costa Rica |
| 2010s | 39.3% | 20.2% | 19.2% | Costa Rica |
| 2020s | 54.8% | 53.5% | 1.2% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Costa Rica or Madagascar?
- Madagascar, at 69.0% against 62.0% in Costa Rica as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Costa Rica and Madagascar?
- 7.0%, with Madagascar ahead.
- How many years of comparable data are there for Costa Rica and Madagascar?
- 15 years are reported by both, from 2006 to 2024.
- How do Costa Rica and Madagascar rank globally for previously treated cases tested for rr-/mdr-tb?
- Costa Rica ranks 135th and Madagascar ranks 134th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.